Tositumomab

Category: Cancer



Tositumomab Overview

Tositumomab is a murine monoclonal antibody which targets the CD20 antigen produced in mammalian cell.[1] It was combined with iodine-131 to produce a radiopharmaceutical for unsealed source radiotherapy, Iodine-131 Tositumomab (branded as Bexxar), for the treatment of non-Hodgkins lymphoma.[1] It is classified as a IgG2a lambda antibody.[1][2] The drug combination was developed by Corixa which was purchased by GlaxoSmithKline in...

Read more Tositumomab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tositumomab

Recent Tositumomab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tositumomab
  • Injection: 14mg/ml, 20ml
  • Vial: 0.1-0.25mg/ml, 1.1-2.5mg/ml, 14mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Tositumomab or a similar ingredient: (1 result)